CMS Open Payments · Program Year 2024
GastroKlenz, Inc. DBA CloudCath
GastroKlenz, Inc. DBA CloudCath reported $1,167.64 across General Payments, Research, and Ownership to 16 physicians and teaching hospitals across 16 transactions.
- $1.2K Below-median payer
- All-tracks total
- 16 Below-median volume
- Transactions
- 16 Below-median reach
- Recipients
- +$459.33
- General Payments vs PY2023
GastroKlenz, Inc. DBA CloudCath reported $1,167.64 across all CMS Open Payments tracks (General + Research + Ownership) to 16 physicians and teaching hospitals in Program Year 2024 - ranking #1836 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,167.64, averaging $72.98 per recipient.
How GastroKlenz, Inc. DBA CloudCath's $1.2K all-tracks total breaks down
GastroKlenz, Inc. DBA CloudCath's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer gastroklenz-inc-dba-cloudcath GastroKlenz, Inc. DBA CloudCath
$1.2K · #1836/1,925 · 0.0% industry · PY2024
- TOT $1.2K
- RANK #1836
- SHARE 0.0%
- TXN 16
- RCP 16
- CAT 2
- GEN $1.2K
- ΔGEN +$459.33
- TOP1 37.4%
- PY 2024
Volume peers
Nearest volume peer: Lazarus 3D ($1.2K)
GastroKlenz, Inc. DBA CloudCath sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
GastroKlenz, Inc. DBA CloudCath's CMS-reported General Payments increased by $459.33 (+64.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: GASTROKLENZ, INC. DBA CLOUDCATHPY2023: GASTROKLENZ, INC. DBA CLOUDCATHPY2024: GastroKlenz, Inc. DBA CloudCath. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $708.31
- PY2024
- $1,167.64
What the Data Shows for GastroKlenz, Inc. DBA CloudCath
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For GastroKlenz, Inc. DBA CloudCath, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $667.64, accounting for 57.2% of this company's General Payments and 13 transactions.
General Payment Breakdown by Type
GastroKlenz, Inc. DBA CloudCath made 2 types of general payments. "Food and Beverage" is the largest category at $667.64, 57.2% of General Payments.
How GastroKlenz, Inc. DBA CloudCath divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $667.64 | 13 | 57.2% |
| Consulting Fee | $500.00 | 3 | 42.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $895.92 (76.7%) of $1,167.64 in this company's General Payments records across 11 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for GastroKlenz, Inc. DBA CloudCath
The five named recipients with the highest reported General Payments from this company
- 1
Leon Rovner
$436.89 across 5 reported transactions
- 2
Luani Lee
$235.46 across 2 reported transactions
- 3
Yasir Qazi
$91.11 across 1 reported transactions
- 4
Robert Szewc
$75.87 across 1 reported transactions
- 5
Jodumutt Bhat
$56.59 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
GastroKlenz, Inc. DBA CloudCath ranks #1836 of 1,925 by total payments (bottom 5% by spend) but is notably more concentrated than that alone would suggest -- #748 of 1,838 by HHI (top 41% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Perfuze Inc : $756.90 total payments, HHI 2041
- Riggs Hospital Supplies, Inc. : $80.79 total payments, HHI 2040
- Picard Medical Inc. : $2.0K total payments, HHI 2036
- Kedrion Biopharma, Inc. : $96.5K total payments, HHI 2036
- Pharmaceutical Business Consultants Limited : $59.4K total payments, HHI 2034
- ZSFab, Inc. : $34.3K total payments, HHI 2031
- GastroKlenz, Inc. DBA CloudCath (this company) : $1.2K total payments, HHI 2028
- 60 Degrees Pharmaceuticals : $5.2K total payments, HHI 2026
- iSchemaView, Inc. : $178.4K total payments, HHI 2026
- OraPharma, a division of Bausch Health US, LLC : $539.1K total payments, HHI 2014
- Diality Inc. : $1.5K total payments, HHI 2011
- FUJIFILM Corporation : $77.8K total payments, HHI 2008
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as GastroKlenz, Inc. DBA CloudCath's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about GastroKlenz, Inc. DBA CloudCath.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with GastroKlenz, Inc. DBA CloudCath.
Showing 6 of 1,924 companies with CMS-reported payment data.
Labcorp Holdings Inc.
Dimension Inx Corp
Nsk America Corporation
Civica, Inc.
Cosette Pharmaceuticals Inc.
Put this to use
GastroKlenz, Inc. DBA CloudCath ranks #1836 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just GastroKlenz, Inc. DBA CloudCath. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.